医疗服务
Search documents
塞力医疗1月13日龙虎榜数据
Zheng Quan Shi Bao Wang· 2026-01-13 10:04
Group 1 - The stock of Saily Medical (603716) decreased by 0.96% today, with a turnover rate of 31.31% and a trading volume of 1.947 billion yuan, showing a fluctuation of 16.53% [2] - The stock was listed on the Shanghai Stock Exchange's "Dragon and Tiger List" due to its high turnover rate, with a net sell of 30.5364 million yuan from the Shanghai-Hong Kong Stock Connect [2] - Over the past six months, the stock has appeared on the Dragon and Tiger List 18 times, with an average price increase of 3.44% the day after being listed and an average increase of 11.40% in the following five days [2] Group 2 - The company's Q3 report for 2025 revealed a total revenue of 857 million yuan for the first three quarters, representing a year-on-year decline of 39.64%, and a net loss of 87.2441 million yuan [2] - The main capital outflow for the stock today was 60.3619 million yuan, with a significant outflow of 21.9535 million yuan from large orders and 38.4084 million yuan from major orders [2] - In the last five days, the stock has seen a total net outflow of 67.7795 million yuan [2]
金域医学(603882.SH):预计2025年年度归属于上市公司股东的净利润为负值
智通财经网· 2026-01-13 09:58
智通财经APP讯,金域医学(603882.SH)发布公告,经公司财务部门初步测算,预计2025年年度归属于 上市公司股东的净利润为负值,公司2025年年度经营业绩将出现亏损,主要原因是由于部分应收账款回 款周期延长,导致产生较大的信用减值损失。 ...
金域医学:预计2025年年度归属于上市公司股东的净利润为负值
Zhi Tong Cai Jing· 2026-01-13 09:54
金域医学(603882)(603882.SH)发布公告,经公司财务部门初步测算,预计2025年年度归属于上市公 司股东的净利润为负值,公司2025年年度经营业绩将出现亏损,主要原因是由于部分应收账款回款周期 延长,导致产生较大的信用减值损失。 ...
昭衍新药:不涉及脑机接口业务
Ge Long Hui· 2026-01-13 09:52
格隆汇1月13日丨昭衍新药(603127.SH)在互动平台表示,公司非人灵长类模型主要是自用,用于非临床 安评实验相关研究,不涉及脑机接口业务。 ...
【兴证策略】60大热门赛道:哪些拥挤度仍在低位?
Xin Lang Cai Jing· 2026-01-13 09:26
Core Insights - The article discusses the investment strategies for the year 2026, focusing on opportunities identified by top fund companies and managers in the market [1][124]. Group 1: Market Sentiment Indicator - The "Congestion Degree" is a unique indicator developed by the company to reflect trading sentiment in popular sectors, combining four dimensions: volume, price, funds, and analyst forecasts [3][126]. - This indicator quantitatively tracks changes in market sentiment and has strong implications for short-term stock price movements [3][126]. Group 2: TMT Sector Insights - The congestion levels for various TMT (Technology, Media, Telecommunications) segments are as follows: - Optical modules: congestion level is moderately low [10][131]. - Servers: congestion level is moderately high [8][133]. - Base stations: congestion level is moderate [10][135]. - Optical fiber and cables: congestion level is moderately high [10][136]. - IDC (Internet Data Center): congestion level is moderately high [10][136]. - Computer equipment: congestion level is high [10][139]. - Optical components: congestion level is high [10][140]. - RF components: congestion level is high [10][145]. - PCB (Printed Circuit Board): congestion level is moderate [10][146]. - IT services: congestion level is moderately high [10][147]. - Semiconductor materials: congestion level is high [10][157]. - Consumer electronics: congestion level is moderately low [10][172]. Group 3: Manufacturing Sector Insights - The congestion levels for various manufacturing segments are as follows: - Automotive parts: congestion level is high [10][181]. - Lithium batteries: congestion level is moderate [10][184]. - Wind power: congestion level is moderately low [10][187]. - Photovoltaic components: congestion level is high [10][197]. - Industrial robots: congestion level is high [10][199]. - Unmanned aerial vehicles: congestion level is high [10][200]. Group 4: Consumer and Pharmaceutical Sector Insights - The congestion levels for various consumer and pharmaceutical segments are as follows: - White goods: congestion level is low [10][207]. - Alcoholic beverages: congestion level is moderately low [10][209]. - Medical services: congestion level is moderately high [10][222]. Group 5: Financial and Real Estate Sector Insights - The congestion levels for various financial and real estate segments are as follows: - Real estate: congestion level is moderate [10][225]. - Insurance: congestion level is high [10][225]. - Banking: congestion level is low [10][226].
博济医药龙虎榜数据(1月13日)
Zheng Quan Shi Bao Wang· 2026-01-13 09:03
Group 1 - Boji Pharmaceutical's stock reached the daily limit increase of 20.00%, with a turnover rate of 22.34% and a total transaction amount of 776 million yuan, showing a volatility of 17.35% [2] - Institutional investors net sold 3.5153 million yuan, while brokerage seats collectively net bought 170 million yuan [2] - The top five brokerage seats accounted for a total transaction amount of 285 million yuan, with a net buying amount of 166 million yuan [2] Group 2 - The main capital inflow for Boji Pharmaceutical was 241 million yuan, with a large single net inflow of 303 million yuan, while large single capital outflow was 62.1141 million yuan [2] - Over the past five days, the net inflow of main capital was 225 million yuan [2] - Specific brokerage seats showed significant buying activity, with the top buying seat contributing 73.2318 million yuan and the second seat contributing 44.5081 million yuan [2]
医疗服务板块1月13日涨4.15%,诺思格领涨,主力资金净流入14.97亿元
Zheng Xing Xing Ye Ri Bao· 2026-01-13 09:00
Core Insights - The medical services sector experienced a significant increase of 4.15% on January 13, with Norska leading the gains [1] - The Shanghai Composite Index closed at 4138.76, down 0.64%, while the Shenzhen Component Index closed at 14169.4, down 1.37% [1] Group 1: Stock Performance - Norska (301333) closed at 76.48, up 20.01% with a trading volume of 55,200 shares and a transaction value of 397 million yuan [1] - Yingsi (301257) also saw a rise of 20.00%, closing at 72.24 with a trading volume of 22,900 shares [1] - Hongbo Pharmaceutical (301230) increased by 20.00%, closing at 56.64 with a trading volume of 57,200 shares [1] - Lanwei Medical (301060) rose by 19.96%, closing at 13.28 with a trading volume of 135,210 shares [1] - Boji Pharmaceutical (300404) increased by 19.96%, closing at 12.92 with a trading volume of 627,100 shares [1] - Dian Diagnostics (300244) saw an increase of 11.90%, closing at 29.16 with a trading volume of 1,516,000 shares [1] Group 2: Capital Flow - The medical services sector saw a net inflow of 1.497 billion yuan from institutional investors, while retail investors experienced a net outflow of 713 million yuan [2] - The main stocks with significant capital flow include International Medical (000516) with a net inflow of 259 million yuan from institutional investors [3] - Boji Pharmaceutical (300404) had a net inflow of 243 million yuan from institutional investors, but also saw a net outflow of 140 million yuan from retail investors [3]
不到4分钟,涨停!封单逾15万手
Xin Lang Cai Jing· 2026-01-13 08:41
Market Overview - The market experienced a pullback today, with the Shanghai Composite Index down by 0.64%, the Shenzhen Component down by 1.37%, the ChiNext Index down by 1.96%, and the Northern Stock 50 Index down by 2.5% [1][15] - The total market turnover reached a record high of 36,987 billion yuan [1][15] Sector Performance - The medical industry chain was active, with the medical services sector showing strength. Notable stocks such as NuoSiGe, HongBo Pharmaceutical, and PuRuiSi hit the daily limit, while MeiNian Health achieved a three-day limit with a market value of 29.005 billion yuan [3][17] - The AI application sector continued its upward trend, with stocks like TongDaHai and TianLong Group also hitting the daily limit [3][18] - The precious metals sector saw significant gains, with stocks like XiaoCheng Technology and Hunan Silver leading the rise [5][20] Precious Metals Market - The precious metals sector was among the top gainers today, with gold prices fluctuating around 4,580 USD per ounce as the market awaited U.S. inflation data [6][21] - The main silver contract closed up nearly 6% [7][22] - The Chicago Mercantile Exchange announced changes to the margin requirements for gold, silver, platinum, and palladium contracts, which may lead to increased caution in market trading [9][24] - Recent geopolitical tensions have heightened market risk aversion, contributing to a strong performance in the precious metals market [9][24] Electric Power Sector - The electric power sector saw a surge in activity in the afternoon, particularly in the power transmission and transformation equipment sector, with stocks like YiNeng Electric and Shuangjie Electric showing significant gains [10][25] - SanBian Technology experienced a rapid increase, hitting the daily limit within four minutes, with a closing price of 17.48 yuan per share [10][25] Renewable Energy Initiatives - The National Energy Administration issued guidelines for the management of renewable energy green power certificates to promote high-quality market development [12][27] - A joint initiative by several government departments aims to expand the application of green electricity in industrial sectors and promote energy conservation and carbon reduction [12][27] Data Center Industry Growth - The data center industry in China is expected to enter a phase of explosive growth, with market size projected to exceed 318 billion yuan by 2025 and reach 1.2 trillion yuan by 2030, driven by increased AI computing demand [13][28]
金域医学:预计2025年归属于上市公司股东的净利润为负值
Mei Ri Jing Ji Xin Wen· 2026-01-13 08:40
每经AI快讯,1月13日,金域医学(603882)(603882.SH)公告称,预计2025年归属于上市公司股东的净 利润为负值,公司2025年经营业绩将出现亏损,主要原因是由于部分应收账款回款周期延长,导致产生 较大的信用减值损失。 ...
第二届国际肿瘤热疗大会共绘绿色抗癌新蓝图
Huan Qiu Wang· 2026-01-13 08:39
来源:环球网 2026年1月10日,由国际临床肿瘤学会(ISCO)、中国抗癌协会肿瘤热疗专委会、中国临床肿瘤学会肿 瘤热疗专家委员会等联合主办,广东药科大学广州复星禅诚医院承办的第二届(广州)国际肿瘤热疗大 会暨中国抗癌协会CACA热疗指南巡讲(广州站)在广州隆重召开。来自国内外知名热疗相关领域的 300余专家参会,报告内容聚焦肿瘤热疗领域的最新理念、最新策略、最新技术、最新成果。 全国肿瘤热疗示范基地(广东药科大学广州复星禅诚医院)揭牌 大会上,广东药科大学广州复星禅诚医院被授予"全国肿瘤热疗示范基地"。肖绍文主委表示,近年来, 广州本土医院肿瘤热疗应用硕果累累,广东药科大学广州复星禅诚医院在肿瘤热疗方面,无论是临床病 例数量还是热疗技术、设备、规模,在全国均处于领先地位,经全国肿瘤热疗协作平台联合专家组综合 评定,决定授予该院为全国示范基地。 "近年来,热疗作为一种绿色、无痛、无创的治疗手段,正以其独特的疗效和强大的兼容性,成为肿瘤 治疗领域的'新利器'。"广东药科大学广州复星禅诚医院谭明华院长介绍说,先进的设备是热疗精准施 治的硬件保障。医院将以此次挂牌为契机,打造集临床、科研、教学、培训于一体的高水平 ...